ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,275Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 1000

$1.13M Total Retail Price of All Prescriptions

Rank: 31 out of 1000

458 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 458 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 458 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 17,392 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 760 690 1 2
LEVOTHYROXINE SODIUM 742 658 2 4
FUROSEMIDE 699 677 3 7
SIMVASTATIN 623 574 4 3
HYDROCODONE-ACETAMINOPHEN 602 471 S3 5 1
AMLODIPINE BESYLATE 597 505 6 6
MIRTAZAPINE 482 481 7 56
POTASSIUM CHLORIDE 452 444 8 10
CITALOPRAM HBR 410 393 9 17
LISINOPRIL 387 354 10 5
DONEPEZIL HCL 317 315 11 32
NAMENDA 302 298 12 43
QUETIAPINE FUMARATE 276 261 13 75
TRAMADOL HCL 275 237 14 13
LOSARTAN POTASSIUM 262 244 15 25
WARFARIN SODIUM 257 256 16 22
HYDROCHLOROTHIAZIDE 257 220 16 9
CYMBALTA 248 228 18 53
FENTANYL 228 226 S2 19 100
GABAPENTIN 216 205 20 11
CLONIDINE HCL 201 164 21 27
METFORMIN HCL 198 184 22 8
CLOPIDOGREL 195 188 23 35
CARVEDILOL 189 173 24 15
METOPROLOL TARTRATE 177 170 25 19
PANTOPRAZOLE SODIUM 176 169 26 28
LEVOFLOXACIN 148 134 27 73
ZOLPIDEM TARTRATE 148 114 27 16
ATORVASTATIN CALCIUM 139 129 29 18
RAMIPRIL 134 125 30 77
ESCITALOPRAM OXALATE 131 127 31 60
SERTRALINE HCL 128 97 32 26
METOPROLOL SUCCINATE 126 126 33 21
LANTUS 118 98 34 68
PLAVIX 117 112 35 49
MELOXICAM 114 95 36 14
TAMSULOSIN HCL 112 103 37 33
ATENOLOL 112 92 37 24
VESICARE 111 97 39 200
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 99 40 20
LACTULOSE 107 84 40 162
CEFUROXIME 105 85 42 133
SEROQUEL 105 100 42 157
DIGOXIN 104 104 44 52
BYSTOLIC 104 89 44 126
EXELON 101 84 46 108
SPIRIVA 88 88 47 64
AMITRIPTYLINE HCL 85 73 R 48 45
FLUOXETINE HCL 83 83 49 51
PREDNISONE 81 76 50 42
RANITIDINE HCL 79 76 51 37
PHENYTOIN SODIUM EXTENDED 79 60 51 115
MUPIROCIN 78 77 53 140
LOVASTATIN 78 71 53 41
HYDRALAZINE HCL 76 51 55 74
SANTYL 76 52 55 249
PRAVASTATIN SODIUM 74 61 57 12
ISOSORBIDE MONONITRATE ER 72 72 58 71
SYNTHROID 71 54 59 91
DIOVAN 70 63 60 67
METOCLOPRAMIDE HCL 69 63 61 99
ZETIA 69 57 61 95
TRAZODONE HCL 69 65 61 29
ROPINIROLE HCL 67 67 64 82
ALLOPURINOL 67 55 64 31
CELEBREX 66 56 66 98
RESTASIS 65 64 67 272
RISPERIDONE 65 64 67 87
LYRICA 64 57 69 47
DIVALPROEX SODIUM 63 63 70 113
RIVASTIGMINE 60 60 71 283
PROMETHAZINE HCL 59 56 R 72 54
LANSOPRAZOLE 58 30 73 190
TRAVATAN Z 58 57 73 286
IPRATROPIUM-ALBUTEROL 58 53 73 212
MECLIZINE HCL 57 57 76 80
FELODIPINE ER 56 44 77 210
POLYETHYLENE GLYCOL 3350 55 55 78 69
PRIMIDONE 55 43 78 228
SPIRONOLACTONE 54 51 80 78
LABETALOL HCL 51 18 81 258
DILTIAZEM 24HR CD 51 47 81 136
NEXIUM 51 51 81 23
HYDROXYZINE HCL 50 49 R 84 153
QUINAPRIL HCL 50 37 84 117
ENABLEX 50 38 84 273
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.